Diffusion Pharmaceuticals (DFFN) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free DFFN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineComparing diffusion, osmosis and active transportbbc.co.uk - April 18 at 11:26 PMDiffusion Pharmaceuticals Inc.thestreet.com - February 10 at 7:21 AMVertex co-founder Josh Boger joins Boston biotech working on dementia drugbizjournals.com - February 8 at 11:10 PMStable Video Diffusion is now available through Stability AI APIventurebeat.com - December 22 at 8:47 PMDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharmafinanznachrichten.de - August 16 at 5:20 AMDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma / Announces 1-for-1.5 Reverse Stock Splitfinanznachrichten.de - August 16 at 5:20 AMDiffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharmafinance.yahoo.com - August 15 at 5:57 PMDiffusion Pharmaceuticals Inc. (DFFN) stock forecast and price targetfinance.yahoo.com - July 24 at 7:24 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFNbenzinga.com - May 23 at 1:35 AMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Diffusion Pharmaceuticals Inc. Mergermarketwatch.com - March 31 at 8:57 AMDFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to Shareholderstechnews.tmcnet.com - March 30 at 2:53 PMDiffusion to merge with EIP Pharma in all-stock dealmsn.com - March 30 at 9:52 AMEIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseasesfinance.yahoo.com - March 30 at 9:52 AMDiffusion's Shareholder LifeSci Supports Company's Strategic Review Process And Director Nomineesmarkets.businessinsider.com - December 16 at 8:55 AMDiffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunitiesfinance.yahoo.com - December 16 at 8:55 AMDiffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealingfinance.yahoo.com - December 5 at 10:09 AMDFFN: Strategic Review Underway; Planning to Initiate Phase 2 GBM Trial in 1Q23…finance.yahoo.com - December 1 at 5:40 PMDiffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 15 at 7:36 AMDiffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Processfinance.yahoo.com - November 14 at 7:21 AMDiffusion Pharmaceuticalsforbes.com - October 15 at 11:06 PMDiffusion Pharmaceuticals Inc. (DFFN)finance.yahoo.com - September 29 at 2:25 PMDiffusion raised to Buy at H.C. Wainwright after Q2 update on lead assetseekingalpha.com - August 17 at 7:57 PMDFFN: Phase 2 GBM Trial to Initiate 2H22…finance.yahoo.com - August 17 at 2:54 PMDiffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - August 11 at 8:25 PMDiffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenationfinance.yahoo.com - July 26 at 11:15 AMDiffusion Pharmaceuticals Announces Positive Effects in Altitude Trialfinance.yahoo.com - June 23 at 8:40 AMDFFN: Data from Altitude Trial Expected in June 2022…finance.yahoo.com - May 20 at 4:13 PMDiffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officerfinance.yahoo.com - May 18 at 8:42 AMDiffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 17 at 7:39 AMDiffusion Pharmaceuticals GAAP EPS of -$2.22seekingalpha.com - May 14 at 8:43 PMDiffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 13 at 1:53 AMDiffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirementsfinance.yahoo.com - May 4 at 8:26 AM5 Stocks Halted In Tuesday's Sessionmarkets.businessinsider.com - April 19 at 7:21 PMDiffusion Pharma Falls 18% After Announcing Reverse Stock Splitnasdaq.com - April 19 at 2:21 PMmarketbeat.com - April 19 at 9:37 AMDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Planfinanznachrichten.de - April 19 at 9:20 AMWhy Diffusion Pharmaceuticals Shares Are Fallinguk.investing.com - April 18 at 2:32 PMDiffusion Pharma crashes after announcing reverse stock splitseekingalpha.com - April 18 at 2:32 PMDiffusion Pharmaceuticals' 50-For-1 Stock Split Will Go Into Effect Tomorrowfinance.yahoo.com - April 18 at 2:32 PMDiffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Planfinance.yahoo.com - April 18 at 9:28 AMDiffusion Pharmaceuticals Completes Dosing in Altitude Trialfinance.yahoo.com - April 11 at 11:42 AMDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholdersfinance.yahoo.com - April 8 at 11:21 AMDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholdersfinance.yahoo.com - April 8 at 11:21 AMDFFN: Additional Tissue Oxygenation Trial Results Expected Mid-2022…finance.yahoo.com - March 23 at 4:43 PMDiffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Updatefinance.yahoo.com - March 21 at 10:40 AMWe're Keeping An Eye On Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Ratefinance.yahoo.com - March 9 at 7:44 AMDiffusion Pharmaceuticals Expands its Scientific Advisory Board with the Addition of Leading Radiation and Medical Oncology Expertsfinance.yahoo.com - February 24 at 9:33 AMDiffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”finance.yahoo.com - December 20 at 9:45 AMDiffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trialfinance.yahoo.com - December 16 at 10:03 AMDiffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523finance.yahoo.com - December 1 at 8:36 AM Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 DFFN Media Mentions By Week DFFN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DFFN News Sentiment▼0.000.46▲Average Medical News Sentiment DFFN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DFFN Articles This Week▼10▲DFFN Articles Average Week Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MTEM News Today ADIL News Today LGVN News Today HEPA News Today AKTX News Today BFRI News Today GRTX News Today VIRI News Today CYCN News Today AEZS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DFFN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diffusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
